Assessing the Health and Economic Impact of Galantamine Treatment in Patients with Alzheimer’s Disease in the Health Care Systems of Different Countries

Authors:

Caro J, Salas M, Ward A, Getsios D, Migliaccio-Walle K, Garfield F

Publication type:

Journal article

Publication name:

Drugs & Aging

Citation:

Caro J, Salas M, Ward A, Getsios D, Migliaccio-Walle K, Garfield F. Assessing the Health and Economic Impact of Galantamine Treatment in Patients with Alzheimer’s Disease in the Health Care Systems of Different Countries. Drugs and Aging. 2004; 21(10):677-86.

Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies